Post hoc analysis of the PLUSS trial in 601 surfactant-treated infants born before 26 weeks: intubation at birth fell from 97% (22–23 weeks) to 64% (25 weeks); reintubation 66% vs 38%; median ventilation 36 vs 12 days in survivors to 36 weeks.
Secondary analysisn = 601
Martinez et al. Respiratory trajectories of infants born before 26 weeks of gestation from birth to discharge: an exploratory analysis of a randomised controlled trial